{"id":"NCT04660643","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss","officialTitle":"Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-03-29","primaryCompletion":"2023-04-25","completion":"2023-05-18","firstPosted":"2020-12-09","resultsPosted":"2024-05-22","lastUpdate":"2024-05-22"},"enrollment":783,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Obesity","Overweight"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tirzepatide (lead-in)","type":"EXPERIMENTAL"},{"label":"Tirzepatide MTD","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This was a study of tirzepatide in participants with obesity or overweight. The main purpose was to learn more about how tirzepatide maintained body weight loss. The study had two phases: a lead-in phase in which all participants took tirzepatide and a treatment phase in which participants either continued tirzepatide or switched to placebo. The study lasted about 2 years (25 visits).","primaryOutcome":{"measure":"Percent Change From Randomization in Body Weight at Week 88","timeFrame":"Randomization (Week 36), Week 88","effectByArm":[{"arm":"Placebo","deltaMin":14.8,"sd":0.53},{"arm":"Tirzepatide MTD","deltaMin":-6.7,"sd":0.52}],"pValues":[{"comp":"OG000 vs OG001","p":"<.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":70,"countries":["United States","Argentina","Brazil","Puerto Rico","Taiwan"]},"refs":{"pmids":["40903801","40717199","39800653","38078870"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/aK2GGZSCqbdJMNUlhfAVV"]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":782},"commonTop":["Nausea","Diarrhoea","Constipation","Covid-19","Vomiting"]}}